That is fine AICp......the article is about the top 5 Australian med-tech companies benefiting from the current Covid driven telehealth transition.
With RAP mentioned in the top 5 companies the article is relevant........and as previously said, the RSH CEO is buying whilst the RAP CEO is selling.......I just wonder if we wont look back and see that as the biggest indicator of future performance.
All that said I am genuinely interested in RAP, and really hoping to see traction with Coviu!
Rap revenue phase, page-21
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #